Kathiresan co-founded Verve Therapeutics with a vision to create a pipeline of single-course, gene editing therapies focused on addressing the root causes of this highly prevalent and life-threatening disease.
Raj is currently Chief Medical Officer of Marengo Therapeutics and sits on the Boards of the following ATP portfolio companies: Nereid Therapeutics, Initial Therapeutics, Adendra Therapeutics and Aulos Bioscience.
In 2021, the Association enabled nearly 800 global volunteers in 22 well-organized public services for patient caring, education support, community engagement and environment protection, in total contributing over 3,100 service hours.
Steve Bates has been leading the UK BioIndustry Association as CEO since 2012.
The OK comes after a Phase II trial dubbed CHELATE, which met primary efficacy endpoints by showing that Cuvrior was not inferior to penicillamine as measured by non-ceruloplasmin copper.
Prior to her current role, Rana was a Transactionalist in Worldwide Business Development at Pfizer where she was responsible for negotiating and transacting licenses, acquisitions, and partnerships across therapeutic areas.